Patents by Inventor Zakir S. Murtaza

Zakir S. Murtaza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7553869
    Abstract: Coumarine/chinolone and Martina-type compounds, compositions, and method of using the compounds and compositions for protein detection, assay, quantitation, etc. are disclosed. The composition, also referred to as a dye, has enhanced sensitivity over commercially available protein stains, and may be used to stain proteins in solution, proteins separated on gels, proteins transferred to solid supports, etc.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: June 30, 2009
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Peter T. Czerney, Surbhi Desai, Frank G. Lehmann, Zakir S. Murtaza, Bernd G. Schweder, Matthias S. Wenzel, Brian David Wolf
  • Publication number: 20080026478
    Abstract: Coumarine/chinolone and Martina-type compounds, compositions, and method of using the compounds and compositions for protein detection, assay, quantitation, etc. are disclosed. The composition, also referred to as a dye, has enhanced sensitivity over commercially available protein stains, and may be used to stain proteins in solution, proteins separated on gels, proteins transferred to solid supports, etc.
    Type: Application
    Filed: July 28, 2006
    Publication date: January 31, 2008
    Applicant: PIERCE BIOTECHNOLOGY, INC.
    Inventors: Peter T. Czerney, Surbhi Desai, Frank G. Lehmann, Zakir S. Murtaza, Bernd G. Schweder, Matthias S. Wenzel, Brian David Wolf
  • Patent number: 7045297
    Abstract: Assays are provided for rapid detection, with high specificity of the pathogenic form of prion protein responsible for neurodegenerative diseases affecting humans and animals, such as transmissible spongiform encephalopathy in bovine, sheep, and cats. Also provided are assays for testing animal feedstock, such as animal feed, for the presence or concentration of pathogenic prion protein. Results are available in from about 0.5 to about 20 minutes and preferably within from about 5 to about 10 minutes. The assays employ proteinase-K to remove normal prion protein from a biological sample, so that the sample may be analyzed by immunochromatography to determine the presence and concentration of pathogenic prion protein. Because the proteinase-K is immobilized on a solid support for in situ removal of interfering components, the present invention obviates the need for subsequent extraction of the desired analyte.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: May 16, 2006
    Assignee: Prion Developmental Laboratories, Inc.
    Inventors: Kiamars Hajizadeh, Zakir S. Murtaza
  • Publication number: 20030092090
    Abstract: Test devices, systems, and test kits are provided for rapid detection with high specificity of the pathogenic form of prion protein responsible for neurodegenerative diseases affecting humans and animals, such as transmissible spongiform encephalopathy in bovine, sheep, and cats. The present invention is also useful for testing animal feedstock made from animal parts. Results are available in from about 0.5 to about 20 minutes and preferably from about 5 to about 10 minutes after the sample is introduced to the device and system. The devices, systems, and test kits employ proteinase-K to remove noninfectious prion protein from a biological sample, so that the sample may be analyzed by immunochromatography to determine the presence and concentration of pathogenic prion protein. Because the proteinase-K is immobilized on a solid support for in-situ removal of interfering components, the present invention obviates the need for subsequent extraction of the desired analyte.
    Type: Application
    Filed: November 14, 2001
    Publication date: May 15, 2003
    Inventors: Kiamars Hajizadeh, Zakir S. Murtaza